MICHELLE GRIFFIN plan to sell securities of ADAPTIVE BIOTECHNOLOGIES CORPORATION under Form 144

MICHELLE GRIFFIN filed Form 144 to notify SEC of plan to sell 52084 units of ADAPTIVE BIOTECHNOLOGIES CORPORATION securities around 2026-06-25, with aggregate market value of $1,007,304.56. The total outstanding units is 160044392.0. The amount planned to be sold represents 0.03% of total outstanding units;